Genolution Inc. (KOSDAQ:225220)
South Korea · Delayed Price · Currency is KRW 2,240.00
+85.00 (3.94%)
At close: Oct 30, 2025
Genolution Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Net Income | -10,257 | -6,826 | -5,512 | 14,602 |
Depreciation & Amortization | 2,366 | 2,041 | 1,578 | 1,328 |
Loss (Gain) From Sale of Assets | 44.22 | - | 2,577 | -218.54 |
Asset Writedown & Restructuring Costs | 12.5 | 17 | 141.55 | - |
Loss (Gain) From Sale of Investments | 2,957 | 3,118 | -542.13 | 459.01 |
Loss (Gain) on Equity Investments | - | 103.43 | -382.21 | 144.85 |
Provision & Write-off of Bad Debts | 67.54 | 133.42 | -66.02 | 123.94 |
Other Operating Activities | -1,460 | 334.95 | -113.97 | -5,301 |
Change in Accounts Receivable | -62.05 | 24.11 | 1,412 | 5,192 |
Change in Inventory | -1,042 | -582.32 | 705.03 | -2,178 |
Change in Accounts Payable | 421.07 | 167.59 | -126.35 | -313.37 |
Change in Other Net Operating Assets | 204.66 | 35.96 | -806.85 | -287.99 |
Operating Cash Flow | -6,747 | -1,433 | -1,136 | 13,551 |
Capital Expenditures | -4,037 | -12,125 | -6,805 | -22,506 |
Sale of Property, Plant & Equipment | -3.3 | - | 2.5 | 115.38 |
Sale (Purchase) of Intangibles | -109.24 | -61.22 | -78.65 | 642.92 |
Investment in Securities | 28,603 | 37,294 | -279.52 | -29,700 |
Other Investing Activities | 10.6 | 630.1 | 80 | -9.61 |
Investing Cash Flow | 24,413 | 25,688 | -7,078 | -51,457 |
Short-Term Debt Issued | - | 4,500 | 17,800 | - |
Long-Term Debt Issued | - | 19,500 | - | 15,000 |
Total Debt Issued | 24,000 | 24,000 | 17,800 | 15,000 |
Short-Term Debt Repaid | - | -9,000 | -8,800 | - |
Long-Term Debt Repaid | - | -15,187 | -63.74 | -2,040 |
Total Debt Repaid | -24,283 | -24,187 | -8,864 | -2,040 |
Net Debt Issued (Repaid) | -282.73 | -186.69 | 8,936 | 12,960 |
Repurchase of Common Stock | - | - | -2,016 | -2,000 |
Dividends Paid | - | - | - | -1,810 |
Other Financing Activities | 292.06 | 559.9 | 238.21 | -0 |
Financing Cash Flow | 9.33 | 373.2 | 7,159 | 9,150 |
Foreign Exchange Rate Adjustments | 1,388 | 1,463 | -161.96 | 2,141 |
Miscellaneous Cash Flow Adjustments | 0 | 0 | - | 0 |
Net Cash Flow | 19,063 | 26,091 | -1,217 | -26,615 |
Free Cash Flow | -10,785 | -13,558 | -7,940 | -8,955 |
Free Cash Flow Margin | -123.01% | -190.00% | -81.34% | -23.51% |
Free Cash Flow Per Share | -597.16 | -750.87 | -432.81 | -474.38 |
Cash Interest Paid | 829.07 | 393.37 | 738.46 | 348.31 |
Cash Income Tax Paid | 22.98 | -859.89 | 290.58 | 6,661 |
Levered Free Cash Flow | -9,090 | -15,004 | -8,593 | - |
Unlevered Free Cash Flow | -8,557 | -14,742 | -8,593 | - |
Change in Working Capital | -477.87 | -354.66 | 1,184 | 2,413 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.